1.
Recent advances in Monoclonal antibodies based formulation used in the management of CRC. Journal of Pharmaceutical Negative Results [Internet]. 2022 Oct. 6 [cited 2026 Jun. 3];:324-38. Available from: https://pnrjournal.com/index.php/home/article/view/1663